229 related articles for article (PubMed ID: 25638569)
1. Chalcones and their therapeutic targets for the management of diabetes: structural and pharmacological perspectives.
Mahapatra DK; Asati V; Bharti SK
Eur J Med Chem; 2015 Mar; 92():839-65. PubMed ID: 25638569
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of chalcones as cardiovascular agents.
Mahapatra DK; Bharti SK
Life Sci; 2016 Mar; 148():154-72. PubMed ID: 26876916
[TBL] [Abstract][Full Text] [Related]
3. Re-exploring promising α-glucosidase inhibitors for potential development into oral anti-diabetic drugs: Finding needle in the haystack.
Ghani U
Eur J Med Chem; 2015 Oct; 103():133-62. PubMed ID: 26344912
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, α-glucosidase inhibitory and molecular docking studies of prenylated and geranylated flavones, isoflavones and chalcones.
Sun H; Li Y; Zhang X; Lei Y; Ding W; Zhao X; Wang H; Song X; Yao Q; Zhang Y; Ma Y; Wang R; Zhu T; Yu P
Bioorg Med Chem Lett; 2015 Oct; 25(20):4567-71. PubMed ID: 26351039
[TBL] [Abstract][Full Text] [Related]
5. The management of diabetes mellitus-imperative role of natural products against dipeptidyl peptidase-4, α-glucosidase and sodium-dependent glucose co-transporter 2 (SGLT2).
Abbas G; Al Harrasi A; Hussain H; Hamaed A; Supuran CT
Bioorg Chem; 2019 May; 86():305-315. PubMed ID: 30738330
[TBL] [Abstract][Full Text] [Related]
6. Investigation of α-glucosidase and α-amylase inhibitory effects of phenoxy chalcones and molecular modeling studies.
Kurşun-Aktar BS; Adem Ş; Tatar-Yilmaz G; Hameed ZAH; Oruç-Emre EE
J Mol Recognit; 2023 Nov; 36(11):e3061. PubMed ID: 37720970
[TBL] [Abstract][Full Text] [Related]
7. Diarylheptanoid-chalcone hybrids with PTP1B and α-glucosidase dual inhibition from Alpinia katsumadai.
He XF; Chen JJ; Li TZ; Hu J; Zhang XM; Geng CA
Bioorg Chem; 2021 Mar; 108():104683. PubMed ID: 33545534
[TBL] [Abstract][Full Text] [Related]
8. Anti-Diabetic Activity of 2,3,6-Tribromo-4,5-Dihydroxybenzyl Derivatives from
Paudel P; Seong SH; Park HJ; Jung HA; Choi JS
Mar Drugs; 2019 Mar; 17(3):. PubMed ID: 30875760
[TBL] [Abstract][Full Text] [Related]
9. Identification of PTP1B and α-Glucosidase Inhibitory Serrulatanes from Eremophila spp. by Combined use of Dual High-Resolution PTP1B and α-Glucosidase Inhibition Profiling and HPLC-HRMS-SPE-NMR.
Wubshet SG; Tahtah Y; Heskes AM; Kongstad KT; Pateraki I; Hamberger B; Møller BL; Staerk D
J Nat Prod; 2016 Apr; 79(4):1063-72. PubMed ID: 26960032
[TBL] [Abstract][Full Text] [Related]
10. Synthesis & α-glucosidase inhibitory & glucose consumption-promoting activities of flavonoid-coumarin hybrids.
Sun H; Song X; Tao Y; Li M; Yang K; Zheng H; Jin Z; Dodd RH; Pan G; Lu K; Yu P
Future Med Chem; 2018 May; 10(9):1055-1066. PubMed ID: 29676183
[TBL] [Abstract][Full Text] [Related]
11. A study towards drug discovery for the management of type 2 diabetes mellitus through inhibition of the carbohydrate-hydrolyzing enzymes α-amylase and α-glucosidase by chalcone derivatives.
Rocha S; Sousa A; Ribeiro D; Correia CM; Silva VLM; Santos CMM; Silva AMS; Araújo AN; Fernandes E; Freitas M
Food Funct; 2019 Sep; 10(9):5510-5520. PubMed ID: 31414099
[TBL] [Abstract][Full Text] [Related]
12. Dual inhibition of the α-glucosidase and butyrylcholinesterase studied by molecular field topology analysis.
Jabeen F; Oliferenko PV; Oliferenko AA; Pillai GG; Ansari FL; Hall CD; Katritzky AR
Eur J Med Chem; 2014 Jun; 80():228-42. PubMed ID: 24780600
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, docking and biological evaluation of chalcones as promising antidiabetic agents.
Rammohan A; Bhaskar BV; Venkateswarlu N; Gu W; Zyryanov GV
Bioorg Chem; 2020 Jan; 95():103527. PubMed ID: 31911298
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review on Anti-diabetic Properties of Chalcones.
Rocha S; Ribeiro D; Fernandes E; Freitas M
Curr Med Chem; 2020; 27(14):2257-2321. PubMed ID: 30277140
[TBL] [Abstract][Full Text] [Related]
15. Analogues of xanthones--Chalcones and bis-chalcones as α-glucosidase inhibitors and anti-diabetes candidates.
Cai CY; Rao L; Rao Y; Guo JX; Xiao ZZ; Cao JY; Huang ZS; Wang B
Eur J Med Chem; 2017 Apr; 130():51-59. PubMed ID: 28242551
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of anti-diabetic and alpha glucosidase inhibitory action of anthraquinones from Rheum emodi.
Arvindekar A; More T; Payghan PV; Laddha K; Ghoshal N; Arvindekar A
Food Funct; 2015 Aug; 6(8):2693-700. PubMed ID: 26145710
[TBL] [Abstract][Full Text] [Related]
17. Microbial transformation of the anti-diabetic agent corosolic acid by Cunninghamella echinulata.
Feng X; Lu YH; Liu Z; Li DP; Zou YX; Fang YQ; Chu ZY
J Asian Nat Prod Res; 2017 Jul; 19(7):645-650. PubMed ID: 27240189
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and molecular docking studies of potent α-glucosidase inhibitors based on biscoumarin skeleton.
Khan KM; Rahim F; Wadood A; Kosar N; Taha M; Lalani S; Khan A; Fakhri MI; Junaid M; Rehman W; Khan M; Perveen S; Sajid M; Choudhary MI
Eur J Med Chem; 2014 Jun; 81():245-52. PubMed ID: 24844449
[TBL] [Abstract][Full Text] [Related]
19. A comprehensive review on xanthone derivatives as α-glucosidase inhibitors.
Santos CMM; Freitas M; Fernandes E
Eur J Med Chem; 2018 Sep; 157():1460-1479. PubMed ID: 30282319
[TBL] [Abstract][Full Text] [Related]
20. Anti-cancer chalcones: Structural and molecular target perspectives.
Mahapatra DK; Bharti SK; Asati V
Eur J Med Chem; 2015 Jun; 98():69-114. PubMed ID: 26005917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
